Literature DB >> 26258316

Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?

Eran Sadot1, Bas Groot Koerkamp, Julie N Leal, Jinru Shia, Mithat Gonen, Peter J Allen, Ronald P DeMatteo, T Peter Kingham, Nancy Kemeny, Leslie H Blumgart, William R Jarnagin, Michael I DʼAngelica.   

Abstract

OBJECTIVES: The impact of margin width on overall survival (OS) in the context of other prognostic factors after resection for colorectal liver metastases is unclear. We evaluated the relationship between resection margin and OS utilizing high-resolution histologic distance measurements.
METHODS: A single-institution prospectively maintained database was queried for all patients who underwent an initial complete resection of colorectal liver metastases between 1992 and 2012. R1 resection was defined as tumor cells at the resection margin (0 mm). R0 resection was further divided into 3 groups: 0.1 to 0.9 mm, 1 to 9 mm, and 10 mm or greater.
RESULTS: A total of 4915 liver resections were performed at Memorial Sloan Kettering Cancer Center between 1992 and 2012, from which 2368 patients were included in the current study. Half of the patients presented with synchronous disease, 43% had solitary metastasis, and the median tumor size was 3.4 cm. With a median follow-up for survivors of 55 months, the median OS of the R1, 0.1 to 0.9 mm, 1 to 9 mm, and 10 mm or more groups was 32, 40, 53, and 56 months, respectively (P < 0.001). Compared with R1 resection, all margin widths, including submillimeter margins correlated with prolonged OS (P < 0.05). The association between the margin width and OS remained significant when adjusted for all other clinicopathologic prognostic factors.
CONCLUSIONS: Resection margin width is independently associated with OS. Wide margins should be attempted whenever possible. However, resection should not be precluded if narrow margins are anticipated, as submillimeter margin clearance is associated with improved survival. The prolonged OS observed with submillimeter margins is likely a microscopic surrogate for the biologic behavior of a tumor rather than the result of surgical technique.

Entities:  

Mesh:

Year:  2015        PMID: 26258316      PMCID: PMC4533113          DOI: 10.1097/SLA.0000000000001427

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  28 in total

1.  The morphological growth patterns of colorectal liver metastases are prognostic for overall survival.

Authors:  Kåre Nielsen; Hans C Rolff; Rikke L Eefsen; Ben Vainer
Journal:  Mod Pathol       Date:  2014-05-23       Impact factor: 7.842

2.  Prognosis according to histochemical analysis of liver metastases removed at liver resection.

Authors:  S M Brunner; R Kesselring; C Rubner; M Martin; T Jeiter; T Boerner; P Ruemmele; H J Schlitt; S Fichtner-Feigl
Journal:  Br J Surg       Date:  2014-10-21       Impact factor: 6.939

Review 3.  Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens.

Authors:  Stéphanie Truant; Cédric Séquier; Emmanuelle Leteurtre; Emmanuel Boleslawski; Mehdi Elamrani; Guillemette Huet; Alain Duhamel; Mohamed Hebbar; François-René Pruvot
Journal:  HPB (Oxford)       Date:  2014-07-09       Impact factor: 3.647

4.  Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer.

Authors:  R Lunevicius; H Nakanishi; S Ito; K Kozaki; T Kato; M Tatematsu; K Yasui
Journal:  J Cancer Res Clin Oncol       Date:  2001       Impact factor: 4.553

5.  Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity.

Authors:  J M Daly; N Kemeny; P Oderman; J Botet
Journal:  Arch Surg       Date:  1984-08

6.  Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection.

Authors:  Norihiro Kokudo; Yoshio Miki; Sachiko Sugai; Akio Yanagisawa; Yo Kato; Yoshihiro Sakamoto; Junji Yamamoto; Toshiharu Yamaguchi; Tetsuichiro Muto; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2002-07

7.  R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

Authors:  Robbert J de Haas; Dennis A Wicherts; Eduardo Flores; Daniel Azoulay; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

8.  A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases.

Authors:  Camilo Correa-Gallego; Yuman Fong; Mithat Gonen; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; William R Jarnagin; T Peter Kingham
Journal:  Ann Surg Oncol       Date:  2014-06-03       Impact factor: 5.344

9.  Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.

Authors:  Kenneth Cardona; Dino Donataccio; T Peter Kingham; Peter J Allen; Ronald P DeMatteo; Yuman Fong; William R Jarnagin; Andrea Cercek; Nancy E Kemeny; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2013-11-18       Impact factor: 5.344

10.  Resection of colorectal liver metastases.

Authors:  J Scheele; R Stang; A Altendorf-Hofmann; M Paul
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

View more
  56 in total

1.  The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.

Authors:  John M Creasy; Eran Sadot; Bas Groot Koerkamp; Joanne F Chou; Mithat Gonen; Nancy E Kemeny; Leonard B Saltz; Vinod P Balachandran; T Peter Kingham; Ronald P DeMatteo; Peter J Allen; William R Jarnagin; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2017-11-27       Impact factor: 5.344

2.  Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.

Authors:  Jian Zheng; Deborah Kuk; Mithat Gönen; Vinod P Balachandran; T Peter Kingham; Peter J Allen; Michael I D'Angelica; William R Jarnagin; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2016-12-05       Impact factor: 5.344

3.  R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.

Authors:  Luca Viganò; Guido Costa; Matteo Maria Cimino; Fabio Procopio; Matteo Donadon; Daniele Del Fabbro; Jacques Belghiti; Norihiro Kokudo; Masatoshi Makuuchi; Jean-Nicolas Vauthey; Guido Torzilli
Journal:  J Gastrointest Surg       Date:  2018-06-08       Impact factor: 3.452

4.  Precoagulation-assisted parenchyma-sparing laparoscopic liver surgery: rationale and surgical technique.

Authors:  Elisa Francone; Elena Muzio; Luigi D'Ambra; Carlo Aschele; Teseo Stefanini; Cinzia Sani; Emilio Falco; Stefano Berti
Journal:  Surg Endosc       Date:  2016-07-21       Impact factor: 4.584

5.  Extending the Limits of Resection for Colorectal Liver Metastases: Positive Resection Margin and Outcome After Resection of Colorectal Cancer Liver Metastases.

Authors:  Motaz Qadan; Michael I D'Angelica
Journal:  J Gastrointest Surg       Date:  2016-09-01       Impact factor: 3.452

6.  Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.

Authors:  Kiyohiko Omichi; Junichi Shindoh; Jordan M Cloyd; Takashi Mizuno; Yun Shin Chun; Claudius Conrad; Thomas A Aloia; Ching-Wei D Tzeng; Jean-Nicolas Vauthey
Journal:  Eur J Surg Oncol       Date:  2017-11-24       Impact factor: 4.424

7.  RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.

Authors:  Kristoffer Watten Brudvik; Yoshihiro Mise; Michael Hsiang Chung; Yun Shin Chun; Scott E Kopetz; Guillaume Passot; Claudius Conrad; Dipen M Maru; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2016-03-25       Impact factor: 5.344

8.  Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.

Authors:  B C Odisio; S Yamashita; S Y Huang; S Harmoush; S E Kopetz; K Ahrar; Y Shin Chun; C Conrad; T A Aloia; S Gupta; M E Hicks; J-N Vauthey
Journal:  Br J Surg       Date:  2017-02-27       Impact factor: 6.939

9.  Margin Status is Still an Important Prognostic Factor in Hepatectomies for Colorectal Liver Metastases: A Propensity Score Matching Analysis.

Authors:  Riccardo Memeo; Vito de Blasi; Rene Adam; Diane Goéré; Tullio Piardi; Emilie Lermite; Olivier Turrini; Francis Navarro; Nicola de'Angelis; Antonio Sa Cunha; Patrick Pessaux
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

Review 10.  Outcome quality standards for surgery of colorectal liver metastasis.

Authors:  Manuel Bellver Oliver; Javier Escrig-Sos; Fernando Rotellar Sastre; Ángel Moya-Herráiz; Luis Sabater-Ortí
Journal:  Langenbecks Arch Surg       Date:  2020-06-23       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.